How to Sell an Urgent Care Center in 2026: Multiples, Named PE Buyers, and the Operator Playbook

If you own an urgent care center or a small chain and you are starting to think about a sale, the M&A market in 2026 is one of the more active corners of healthcare services. Roughly 13,000 urgent care centers operate across the US per Urgent Care Association (UCA) benchmark data, and somewhere around 22 percent are now private-equity-backed, either directly or through hospital-system JVs. Urgent care fits the buy-and-build playbook almost perfectly: site-level cash flow, repeatable build-outs, defensible payor contracts, and clear room for back-office consolidation.

This guide walks through what an urgent care center is worth in 2026, who the named buyers are, how the UCA accreditation premium works, how payor mix and CMS POS 20 coding affect value, what state UC licensure looks like in FL, NY, TX, and CA, and what a real 4-clinic Florida deal looks like end to end.

The urgent care industry in 2026: roughly 13,000 centers, ~22 percent PE-owned

UCA tracks the universe at roughly 13,000 urgent care centers operating across the US, up from about 8,100 a decade ago. Visit volumes grew through the COVID era, normalized in 2023, and are once again expanding in the mid-single-digit range as employer-sponsored health plans push members to lower-cost ambulatory settings. Typical mature urgent care centers run $1.5M-$2.5M of revenue per site, 12-18 percent site-level EBITDA margins, and 35 to 60 patient visits per day at full ramp.

Ownership has consolidated rapidly. Roughly 22 percent of US urgent care centers are now PE-backed, either directly or through hospital-system JVs that themselves have PE capital behind them. Another 25-30 percent sit inside hospital systems and IDNs directly. The remaining half is independent: solo physician owners, two-doctor partnerships, regional small groups of two to seven clinics. That independent half is where most current deal activity sits.

Two structural tailwinds keep the buyer pool deep:

• Site-of-service economics. Commercial health plans pay roughly $150-$200 for an urgent care visit versus $700-$1,200 for an emergency department visit for the same complaint. Payors are explicitly steering members to urgent care.
• Occupational health crossover. Workers' comp, employer drug screens, DOT physicals, and on-site clinic services add a high-margin revenue layer that commercial-only chains often miss. Concentra (Select Medical) built a 500-plus-clinic platform on this thesis.

Valuation math: what it takes to sell an urgent care center for the top multiple

Urgent care valuation in 2026 keys off three variables: scale, payor mix, and operating maturity. The base ranges are wide because the operator-quality spread inside urgent care is wider than almost any other healthcare services sub-vertical.

The ranges above are pre-synergy. Strategic buyers occasionally pay above the top of the band for clean geographic fill-in (think a regional PE platform that needs a specific MSA to lock in a payor contract or to hit a population threshold for a value-based-care contract). They almost never pay above the band for an asset that requires real cleanup.

EBITDA add-backs buyers will actually allow

The EBITDA that goes into the multiple is adjusted EBITDA, not reported EBITDA. Reasonable add-backs that pass Quality of Earnings (QoE) diligence include: above-market owner-physician compensation (normalized to market W-2 medical-director comp), one-time legal and accounting fees, COVID-era PPE stockpile write-downs, non-recurring marketing campaigns, related-party rent above market, and personal expenses incorrectly run through the P&L. Add-backs buyers will challenge or deny: ongoing physician recruiter fees (those are recurring), routine equipment refresh (capex disguised as opex), benefits-program enrichments, and bonus comp that is in fact retention-critical.

A practical rule: every dollar of contested add-back that gets removed at QoE costs the seller roughly the multiple itself. At a 10x multiple, $200k of disallowed add-backs costs $2M of enterprise value. This is why a seller-side QoE before going to market is almost always money well spent for any deal above $5M of EBITDA.

The Urgent Care Association (UCA) accreditation premium

Urgent Care Association (UCA) accreditation, formerly called the Certified Urgent Care designation, is the single most recognized quality marker in the industry. It signals to buyers that the center meets minimum staffing standards (a physician on-site or immediately accessible, ACLS/PALS-trained staff), maintains an on-site lab and X-ray, and follows standardized treat-and-release protocols for common acuity ranges.

Two effects show up in market: priced-in buyer preference and contract pricing power. Accredited centers move through clinical diligence roughly 30 percent faster, and several PE platforms will not even underwrite an unaccredited single site at a competitive multiple. The pricing-power effect is just as important: accredited centers tend to negotiate stronger commercial payor contracts because they can prove they sit in the commercially preferred ambulatory tier. In multi-site deals, blended UCA accreditation coverage of 80 percent+ across the portfolio typically supports a 0.5x to 1.5x EBITDA premium on the multiple.

If accreditation is not currently in place, it is usually possible to accredit one to three centers as a pilot before going to market. Buyers will still discount accordingly, but partial accreditation plus a documented roll-out plan is materially better than no accreditation at all.

Payor mix: the silent multiple killer when you sell an urgent care center

No single operating variable moves the urgent care multiple as much as payor mix. The right way to present payor mix to a buyer is by share of net revenue, not visit count, because the reimbursement spread between a commercial visit and a self-pay or Medicaid visit can be 3-to-1 or worse.

Buyers also care about commercial-payor concentration. A center where BCBS represents 45 percent of net revenue carries real concentration risk because a single fee schedule renegotiation can swing 15-25 percent of revenue. Multi-payor centers (no single commercial payor above 25 percent of net revenue) usually price 0.5x to 1.5x higher on multiple than concentrated centers of identical EBITDA.

CMS POS 20 and the off-campus urgent care coding discipline

Every urgent care visit billed to a federal payor carries a place-of-service (POS) code. CMS POS 20 is the official designation for an off-campus urgent care facility, distinct from POS 11 (physician office) and POS 22 (on-campus hospital outpatient). Using POS 20 correctly does three things buyers care about: it documents that the center is in fact an urgent care under federal definitions, it supports the urgent care visit-level reimbursement, and it protects the revenue stream from retroactive payor recoupment.

Two coding habits show up in Quality of Earnings reviews on nearly every urgent care deal. First, S9083 (global per-visit urgent care code) and S9088 (urgent care add-on code) are commercial-payor codes that some commercial plans require and others reject. Centers that use S-codes correctly capture an extra $25-$60 per qualifying visit on plans that pay them; centers that use them on plans that do not pay them generate denials and AR runoff. Second, E/M level-of-service distribution should sit roughly 5-15-50-25-5 across CPT 99202 through 99205 for new patients and similar across 99212-99215 for established patients. A center over-coding 99204 and 99205 above 35 percent invites a buyer-side audit that almost always ends in a downward revenue restatement.

Clean CMS POS 20 discipline plus defensible E/M distribution typically protects 95 percent+ of trailing-twelve-month revenue under buyer scrutiny. Sloppy coding can trigger revenue haircuts of 4-9 percent at QoE, which at a 10x multiple is the difference between the seller's walk-away number and a busted deal.

State urgent care licensure: FL, NY, TX, and CA differ materially

Urgent care is regulated at the state level, and the licensure regime varies more than founders usually realize. Buyer counsel will run state-specific licensure exposure analysis on every transaction. The four big-population states behave very differently.

Florida

Florida does not require a separate urgent care license. Centers operate under the supervising physician's medical license, with corporate-practice-of-medicine exposure managed through the standard PA/MSO structure. AHCA registration applies if the center bills Medicaid. Florida is the most transaction-friendly large state for urgent care M&A precisely because the corporate structure is lighter; nearly every PE platform has Florida exposure in the portfolio.

New York

New York is the strictest. Article 28 (NYS Department of Health diagnostic and treatment center licensure) historically applied to many urgent care arrangements, and the state has been tightening the line between a licensed Diagnostic and Treatment Center and a private physician practice. Most NY urgent care groups operate under a Professional Service Corporation (PC) structure with a Management Services Organization (MSO) handling the non-clinical business. New York also has the strongest corporate-practice-of-medicine enforcement in the country. Buyers will spend real legal dollars validating the MSO structure before close.

Texas

Texas requires a Freestanding Emergency Medical Care Facility license only for freestanding emergency rooms, not for urgent care. Urgent care in Texas operates under physician licensure with Texas Medical Board oversight. The Texas corporate-practice-of-medicine rule is enforced; the standard structure is a physician-owned PA paired with an MSO. Texas urgent care centers also benefit from a deep occupational-health market driven by the oil and gas, logistics, and construction sectors.

California

California also enforces a strict corporate-practice-of-medicine doctrine. Urgent care typically operates under a physician-owned Professional Corporation (PC) with an MSO partner. AB 3087 and follow-on California legislation around healthcare M&A approval have introduced state-level notification requirements for certain healthcare transactions; the most relevant for urgent care is the California Office of Health Care Affordability (OHCA) cost and market impact review, which kicks in for transactions above defined thresholds. California is doable for M&A but takes longer to close than Florida or Texas.

Named PE-active urgent care center buyers in 2026

The buyer universe for urgent care splits into four lanes: PE-backed strategics, hospital systems and IDNs, occupational-health platforms, and franchise platforms. Naming buyers makes the universe real for any operator preparing to sell an urgent care center.

US Acute Care Solutions (USACS)

USACS is a physician-owned, PE-backed platform that has expanded from emergency medicine into urgent care through clinical-staffing partnerships and selective platform investments. USACS values physician-led operating teams highly and tends to leave clinical leadership in place post-close.

MedExpress (Schar Healthcare)

MedExpress, which UnitedHealth's Optum acquired in 2015 and operated for nearly a decade, was divested to PE-backed Schar Healthcare in 2024. The divestiture reset MedExpress as an independent platform and re-opened it as a strategic acquirer in markets where it already operates.

NextCare (General Atlantic)

NextCare is a long-standing urgent care platform backed by General Atlantic, operating roughly 175 centers across multiple states. Historically one of the more active acquirers of small regional groups in the Sun Belt and Mountain West. Centralized clinical and RCM model, so tuck-in integration tends to be fast.

ChoiceOne Urgent Care (Sterling Investment Partners)

Recapitalized by Sterling Investment Partners, ChoiceOne runs a Southeast-focused regional platform with acquisition appetite concentrated in the Carolinas, Georgia, and Florida. It is one of the cleaner regional comps for what a 10-to-25-center buy-and-build looks like.

American Family Care / AFC Urgent Care

AFC is a franchise-driven platform with 250-plus locations. The corporate parent (American Family Care) buys back selected franchise locations and acquires independent groups in territories. The franchise lane is a path for a single-site operator to exit at a smaller multiple but with a faster close.

GoHealth Urgent Care (TPG + Kaiser + Northwell)

GoHealth is a TPG-backed platform that scaled primarily through joint ventures with major health systems: Kaiser Permanente (West Coast), Northwell Health (NY metro), Hartford HealthCare (CT), Legacy Health (OR), and Dignity Health (CA). GoHealth typically acquires inside its existing JV geographies.

Worked example: a 4-clinic Florida urgent care doing $3M EBITDA

Consider a 4-clinic Florida urgent care group with these characteristics: $12M of trailing-twelve-month net revenue, $3M of adjusted EBITDA (25 percent margin, above industry average because of meaningful workers' comp revenue), UCA accreditation across all four sites, in-network status with BCBS Florida, Aetna, UHC, Cigna, and Humana, no single payor above 28 percent of revenue, modern athenaOne EMR with a clean RCM tail (DSO 33 days, denial rate 5.8 percent), and a stable physician bench of four MDs plus six PAs.

What the multiple looks like:

• Base multiple for a 4-clinic group at $3M EBITDA: 8x-10x. Call it 9x at the midpoint.
• UCA accreditation premium across all four sites: +0.5x.
• Commercial-heavy payor mix with no concentration: +0.5x.
• Workers' comp / occupational-health revenue layer: supports the top of the range.

Blended multiple: ~10x. Enterprise value at LOI: ~$30M.

Close adjustments include a working capital peg (target ~8 percent of revenue, true-up at close), a rep-and-warranty insurance policy (1.0-1.5 percent of EV premium, ~0.5 percent retention), and a 1-year QoE-driven escrow at 8-12 percent of EV. The seller typically nets 85-90 percent of headline EV in cash at close.

Run the same group with two of four sites unaccredited, BCBS at 45 percent of revenue, and a denial rate of 11 percent, and the same $3M EBITDA more realistically clears 7.0x-7.5x, or $21M-$22.5M of EV. That is a $7-$9M valuation gap on the same EBITDA dollar, which is why the 12-18 months of operating prep before market is where the value gets created.

Due diligence preparation: what buyers will ask for to sell an urgent care center

Urgent care diligence is heavier than non-clinical services M&A because the buyer is taking on regulatory, coding, and clinical-quality risk. A typical buyer data-room request covers six pillars.

1. Financial: 3 years of audited or reviewed financials, TTM P&L by site, monthly EBITDA bridge, capex schedule, AR aging by payor.
2. Payor and revenue: contracts with every commercial payor, fee schedules, claims-level revenue detail, E/M coding distribution by provider, denial-rate trend.
3. Clinical and regulatory: UCA accreditation status by site, state licensure registrations, malpractice claims history, OIG exposure check, controlled-substance dispensing logs.
4. Real estate: lease abstracts for every site, landlord consent provisions, remaining lease term, related-party rent disclosure.
5. People: physician and PA employment agreements, medical-director agreements, non-compete enforceability by state, retention plan.
6. IT and systems: EMR vendor and customization, RCM vendor, scheduling software, security and HIPAA posture, breach history.

The full PE due diligence preparation framework covers every item in detail. Plan on 60-90 days from LOI to close on a clean deal, 120-180 days on a deal with cleanup work.

Adjacent healthcare vertical: home health

The closest adjacent healthcare vertical from a buyer-overlap and multiple-driver perspective is home health. The buyer pool overlaps materially (several PE platforms hold both urgent care and home health assets), the payor-mix discipline is identical, and the EBITDA bridge work feels familiar. If you are evaluating diversification or a roll-up, the home health sale playbook and the more detailed home health business valuation guide are the closest reference points. The structural pattern is also similar to non-healthcare services consolidation: see the commercial HVAC business sale framework for how multi-site service rollups price across other PE-active verticals.

Our point of view on selling an urgent care center in 2026

The market for urgent care center M&A in 2026 remains one of the most buyer-rich corners of healthcare services. PE platforms still have unspent capital and explicit tuck-in mandates, hospital systems are still building outpatient access through urgent care JVs, and the consolidation curve has not yet peaked. The bid-ask spread between operator-quality and bottom-quartile assets has widened: a clean, UCA-accredited, commercially-mixed 3-to-10-clinic group will draw five to eight serious bids; a non-accredited, Medicaid-heavy, RCM-troubled group might draw one or two.

The single best ROI in the 12 months before going to market is operating cleanup: accredit any unaccredited site, tighten E/M and POS 20 discipline, drive denial rate below 7 percent, document the management bench so buyers can underwrite without depending on the founder. None of these moves require capital. All of them lift the multiple. Together they often mean the difference between a 7x deal and a 10x deal on the same EBITDA dollar.

How CT Strategic Partners runs an urgent care center sale process

Our model is buyer-paid: sellers pay nothing at close, and the acquiring buyer pays our success fee. The process for an urgent care center looks like this: confidential valuation intake, buyer mapping against active mandates, NDA-driven sequential introductions through our buyer partner network, structured competitive process to LOI, then Quality of Earnings and confirmatory diligence into close. No retainer. No exclusivity contract.

Frequently asked questions about how to sell an urgent care center

How much is an urgent care center worth in 2026?

A profitable single-site urgent care center with commercial in-network status and clean financials typically clears 5x to 9x adjusted EBITDA. Multi-site groups of 3-9 clinics clear 8x to 12x. Platform-grade chains of 25-plus clinics clear 12x to 15x or more. The base multiple is adjusted up or down for payor concentration, accreditation coverage, EMR cleanliness, and management depth.

Does UCA (Urgent Care Association) accreditation actually move the multiple?

Yes. Across-the-board UCA accreditation on a multi-site group typically supports an extra 0.5x to 1.5x of EBITDA. Buyers move through clinical diligence faster, and accredited centers tend to negotiate stronger commercial payor contracts. For a single site, accreditation is increasingly table stakes; several PE platforms will not underwrite an unaccredited single site competitively.

What payor mix do PE buyers want to see?

The sweet spot is 60 percent+ commercial (BCBS, UHC, Aetna, Cigna, Humana) with no single payor above 25 percent of net revenue, 10-20 percent Medicare and Medicare Advantage, 5-15 percent self-pay collected at point of service, and ideally a layer of workers' comp and occupational health revenue. Medicaid-heavy mixes (above 30 percent of net revenue) compress the multiple by 1x to 3x.

How does CMS POS 20 affect my urgent care sale?

CMS POS 20 is the place-of-service code for an off-campus urgent care facility. Buyers audit POS coding under Quality of Earnings because incorrect POS coding can trigger retroactive payor recoupment. Clean POS 20 usage typically protects 95 percent+ of trailing revenue. Sloppy coding or over-coded E/M distributions can see revenue restated downward 4 to 9 percent at QoE, which directly comes off the headline multiple.

Who are the named PE buyers actively acquiring urgent care centers in 2026?

The most active named PE-backed buyers include US Acute Care Solutions, MedExpress (Schar Healthcare after Optum's 2024 divestiture), NextCare (General Atlantic, 175-plus centers), ChoiceOne Urgent Care (Sterling Investment Partners), AFC Urgent Care (250-plus locations, franchise plus corporate), and GoHealth Urgent Care (TPG-backed with JVs including Kaiser, Northwell, and Hartford HealthCare). Hospital systems and IDNs are also active, typically through JVs.

How do FL, NY, TX, and CA urgent care licensure requirements differ?

Florida does not require a separate urgent care license; centers operate under the supervising physician's license. New York is the strictest, with Article 28 Diagnostic and Treatment Center licensure exposure and the standard PC plus MSO structure. Texas does not require freestanding facility licensure for urgent care, but enforces corporate practice of medicine via the PA-MSO structure. California enforces corporate practice of medicine strictly and now layers OHCA cost-and-market-impact review on top of qualifying transactions. Florida and Texas are the fastest-closing states.

What does the timeline look like from LOI to close on an urgent care deal?

A clean deal closes in 60-90 days from signed LOI. A deal with material cleanup (RCM remediation, accreditation in-progress, NY or CA regulatory review) closes in 120-180 days. Plan on 12-18 months of operating preparation before going to market plus 4-6 months in market and through close.

How much do I net at close after working capital peg and escrow?

Sellers typically net 85-90 percent of headline enterprise value in cash at close. The remainder sits in a working capital true-up (settled within 90 days) and a rep-and-warranty escrow or holdback (8-12 percent of EV, released over 12-24 months). Rep-and-warranty insurance, standard on deals above $10M of EV, runs 1.0-1.5 percent of EV in premium with a retention around 0.5 percent of EV.

Related research

• Sell your home health business
• Home health business valuation guide
• How to sell a commercial HVAC business
• Quality of Earnings explained
• How to prepare for PE due diligence
• How to sell a medical billing company
• How to sell a physical therapy practice
• How to sell a home health agency
• Healthcare business valuation
• Which industries is PE buying most in 2026
• Private equity value creation
• Business broker alternative
• Sell your business (overview)

About the Author

Christoph Totter is the founder of CT Acquisitions, a buy-side partner headquartered in Sheridan, Wyoming. We work directly with 76+ buyers, search funders, family offices, lower middle-market PE, and strategic consolidators, including direct mandates with the largest home services consolidators that other intermediaries can’t access. The buyers pay us when a deal closes, not the seller. No retainer, no exclusivity, no contract until close. Connect on LinkedIn · Get in touch